Knowledge (XXG)

Exosome complex

Source πŸ“

480: 472:
structure of the human exosome has no enzymatically active protein. Despite this loss of catalytic activity, the structure of the core exosome is highly conserved from archaea to humans, suggesting that the complex performs a vital cellular function. In eukaryotes, the absence of the phosphorolytic activity is compensated by the presence of the hydrolytic enzymes, which are responsible for the ribonuclease activity of the exosome in such organisms.
225: 357: 694:(one of the RNase PH like proteins from the ring) and antibodies recognizing these proteins are found in approximately 30% of patients with the PM/Scl overlap syndrome. Although these two proteins are the main target of the autoantibodies, other exosome subunits and associated proteins (like C1D) can be targeted in these patients. At the current time, the most sensitive way to detect these antibodies is by using a 582: 436: 1265: 248: 244:-like proteins. In archaea there are two different PH-like proteins (called Rrp41 and Rrp42), each present three times in an alternating order. Eukaryotic exosome complexes have six different proteins that form the ring structure. Of these six eukaryotic proteins, three resemble the archaeal Rrp41 protein and the other three proteins are more similar to the archaeal Rrp42 protein. 40: 3568:
Wan, J.; Yourshaw, M.; Mamsa, H.; Rudnik-SchΓΆneborn, S.; Menezes, M. P.; Hong, J. E.; Leong, D. W.; Senderek, J.; Salman, M. S.; Chitayat, D.; Seeman, P.; Von Moers, A.; Graul-Neumann, L.; Kornberg, A. J.; Castro-Gago, M.; Sobrido, M. A. J. S.; Sanefuji, M.; Shieh, P. B.; Salamon, N.; Kim, R. C.;
475:
As stated above, the hydrolytic proteins Rrp6 and Rrp44 are associated with the exosome in yeast and in humans, besides Rrp6, two different proteins, Dis3 and Dis3L1 can be associated at the position of the yeast Rrp44 protein. Although originally the S1 domain proteins were thought to have 3'-5'
344:
exosome complexes and has a crucial role in the activity of the yeast exosome complex. While a human homologue of the protein exists, no evidence was found for a long time that its human homologue was associated with the human exosome complex. In 2010, however, it was discovered that humans have
443:
As stated above, the exosome complex contains many proteins with ribonuclease domains. The exact nature of these ribonuclease domains has changed across evolution from bacterial to archaeal to eukaryotic complexes as various activities have been gained and lost. The exosome is primarily a 3'-5'
295:
of some eukaryotic organisms, two RNase PH domains, and both an S1 and KH RNA binding domain are part of a single protein, which forms a trimeric complex that adopts a structure almost identical to that of the exosome. Because of this high similarity in both protein domains and structure, these
471:
In archaea, the Rrp41 subunit of the complex is a phosphorolytic exoribonuclease. Three copies of this protein are present in the ring and are responsible for the activity of the complex. In eukaryotes, none of the RNase PH subunits have retained this catalytic activity, meaning the core ring
398:
Apart from these two tightly bound protein subunits, many proteins interact with the exosome complex in both the cytoplasm and nucleus of cells. These loosely associated proteins may regulate the activity and specificity of the exosome complex. In the cytoplasm, the exosome interacts with
251:
Subunits and organisation of the archaeal (left) and eukaryotic (right) exosome complexes. Different proteins are numbered, showing that the archaeal exosome contains 4 different proteins, but the eukaryotic exosome contains nine different proteins. See the full
403:(ARE) binding proteins (e.g. KRSP and TTP), which can promote or prevent degradation of mRNAs. The nuclear exosome associates with RNA binding proteins (e.g. MPP6/Mpp6 and C1D/Rrp47 in humans/yeast) that are required for processing certain substrates. 452:. Exoribonucleases contained in exosome complexes are either phosphorolytic (the RNase PH-like proteins) or, in eukaryotes, hydrolytic (the RNase R and RNase D domain proteins). The phosphorolytic enzymes use inorganic phosphate to cleave the 340:(nucleases that use water to cleave the nucleotide bonds). In addition to being an exoribonucleolytic enzyme, Rrp44 also has endoribonucleolytic activity, which resides in a separate domain of the protein. In yeast, Rrp44 is associated with 702:, instead of complete proteins. By this method, autoantibodies are found in up to 55% of patients with the PM/Scl overlap syndrome, but they can also be detected in patients with either scleroderma, polymyositis, or dermatomyositis alone. 345:
three Rrp44 homologues and two of these can be associated with the exosome complex. These two proteins most likely degrade different RNA substrates due to their different cellular localization, with one being localized in the cytoplasm (
662:
from human cell extracts. In immunoprecipitation assays with sera from anti-exosome positive sera, a distinctive set of proteins is precipitated. Already years before the exosome complex was identified, this pattern was termed the
268:. In eukaryotes, three different "S1" proteins are bound to the ring, whereas in archaea either one or two different "S1" proteins can be part of the exosome (although there are always three S1 subunits attached to the complex). 483:
Schematic view of the archaeal (left) and eukaryotic (right) exosome complexes with the most common associated proteins. In color and marked with a star are the subunits of each complex that have catalytic activity. See
1809:
Walter, P; Klein, F; Lorentzen, E; Ilchmann, A; Klug, G; Evguenieva-Hackenberg, E (2006). "Characterization of native and reconstituted exosome complexes from the hyperthermophilic archaeon Sulfolobus solfataricus".
605:(CUTs) that are produced from thousands of loci within the yeast genome. The importance of these unstable RNAs and their degradation are still unclear, but similar RNA species have also been detected in human cells. 589:
The exosome is a key complex in cellular RNA quality control. Unlike prokaryotes, eukaryotes possess highly active RNA surveillance systems that recognise unprocessed and mis-processed RNA-protein complexes (such as
1763:
Raijmakers, R; Egberts, WV; Van Venrooij, WJ; Pruijn, GJ (2002). "Protein-protein interactions between human exosome components support the assembly of RNase PH-type subunits into a six-membered PNPase-like ring".
476:
hydrolytic exoribonuclease activity as well, the existence of this activity has recently been questioned and these proteins might have just a role in binding substrates prior to their degradation by the complex.
207:). Purification of this "PM/Scl complex" allowed the identification of more human exosome proteins and eventually the characterization of all components in the complex. In 2001, the increasing amount of 3267:
Raijmakers, R; Renz, M; Wiemann, C; Egberts, WV; Seelig, HP; Van Venrooij, WJ; Pruijn, GJ (2004). "PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome".
1243:
In humans, two different proteins can be associated in this position. In the cytoplasm of cells, Dis3L1 is associated with the exosome, whereas in the nucleus, Dis3 can bind to the core complex.
211:
that had become available allowed the prediction of exosome proteins in archaea, although it would take another 2 years before the first exosome complex from an archaeal organism was purified.
3048:
Neil H, Malabat C, d'Aubenton-Carafa Y, Xu Z, Steinmetz LM, Jacquier A (February 2009). "Widespread bidirectional promoters are the major source of cryptic transcripts in yeast".
1668:
Lorentzen, E; Walter, P; Fribourg, S; Evguenieva-Hackenberg, E; Klug, G; Conti, E (2005). "The archaeal exosome core is a hexameric ring structure with three catalytic subunits".
756:. In yeast cells treated with fluorouracil, defects were found in the processing of ribosomal RNA identical to those seen when the activity of the exosome was blocked by 390:
protein family. The protein PM/Scl-100 is most commonly part of exosome complexes in the nucleus of cells, but can form part of the cytoplasmic exosome complex as well.
509:(mRNA) molecules. The complex can degrade mRNA molecules that have been tagged for degradation because they contain errors, through interactions with proteins from the 3355:
Schilders, G; Egberts, WV; Raijmakers, R; Pruijn, GJ (2007). "C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome".
283:
processing, forms a hexameric ring consisting of six identical RNase PH proteins. In the case of PNPase, which is a phosphorolytic RNA-degrading protein found in
564:, growth stops and the cells eventually die. Both the core proteins of the exosome complex, as well as the two main associated proteins, are essential proteins. 1518:"Prediction of the archaeal exosome and its connections with the proteasome and the translation and transcription machineries by a comparative-genomic approach" 103:
The core of the exosome contains a six-membered ring structure to which other proteins are attached. In eukaryotic cells, the exosome complex is present in the
594:) prior to their exit from the nucleus. It is presumed that this system prevents aberrant complexes from interfering with important cellular processes such as 1896:"Crystal structure of the phosphorolytic exoribonuclease RNase PH from Bacillus subtilis and implications for its quaternary structure and tRNA binding" 195:. Not long after, in 1999, it was realized that the exosome was in fact the yeast equivalent of an already described complex in human cells called the 2921:
Carpousis AJ, AJ (2002). "The Escherichia coli RNA degradosome: structure, function and relationship in other ribonucleolytic multienzyme complexes".
709:
of these patients can vary widely. The symptoms that are seen most often are the typical symptoms of the individual autoimmune diseases and include
2505:
Dziembowski, A; Lorentzen, E; Conti, E; SΓ©raphin, B (2007). "A single subunit, Dis3, is in essence responsible for yeast exosome core activity".
2334:
Raijmakers, R; Schilders, G; Pruijn, GJ (2004). "The exosome, a molecular machine for controlled RNA degradation in both nucleus and cytoplasm".
115:, although different proteins interact with the exosome complex in these compartments regulating the RNA degradation activity of the complex to 3656:
Houseley, J; Tollervey, D (2008). "The nuclear RNA surveillance machinery: the link between ncRNAs and genome structure in budding yeast?".
2236:
Tomecki, R; Kristiansen, MS; Lykke-Andersen, S; Chlebowski, A; Larsen, KM; Szczesny, RJ; Drazkowska, K; Pastula, A; et al. (2010).
725:. Treatment of these patients is symptomatic and is similar to treatment for the individual autoimmune disease, often involving either 328:
Besides these nine core exosome proteins, two other proteins often associate with the complex in eukaryotic organisms. One of these is
647: 3441:
Mahler, M; Raijmakers, R (2007). "Novel aspects of autoantibodies to the PM/Scl complex: Clinical, genetic and diagnostic insights".
1413:
Brouwer, R; Allmang, C; Raijmakers, R; Van Aarssen, Y; Egberts, WV; Petfalski, E; Van Venrooij, WJ; Tollervey, D; Pruijn, GJ (2001).
3638: 1644: 680: 498: 2085:"The N-terminal PIN domain of the exosome subunit Rrp44 harbors endonuclease activity and tethers Rrp44 to the yeast core exosome" 3302:
Brouwer, R; Vree Egberts, WT; Hengstman, GJ; Raijmakers, R; Van Engelen, BG; Seelig, HP; Renz, M; Mierau, R; et al. (2002).
414:(Ski2) and is involved in mRNA degradation. In the nucleus, the processing of rRNA and snoRNA by the exosome is mediated by the 3308: 601:
In addition to RNA processing, turnover and surveillance activities, the exosome is important for the degradation of so-called
537:
is the compartment where the majority of the exosome complexes are found. There it plays a role in the processing of the 5.8S
1945:"A duplicated fold is the structural basis for polynucleotide phosphorylase catalytic activity, processivity, and regulation" 304:. The RNase PH-like exosome proteins, PNPase and RNase PH all belong to the RNase PH family of RNases and are phosphorolytic 135:
in this case), and in eukaryotes also an endoribonucleolytic function, meaning it cleaves RNA at sites within the molecule.
2133: 3571:"Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration" 760:
strategies. Lack of correct ribosomal RNA processing is lethal to cells, explaining the antimetabolic effect of the drug.
240:
The core of the complex has a ring structure consisting of six proteins that all belong to the same class of RNases, the
569: 568:
do not have an exosome complex; however, similar functions are performed by a simpler complex that includes the protein
276: 1986:"The PNPase, exosome and RNA helicases as the building components of evolutionarily-conserved RNA degradation machines" 705:
As the autobodies are found mainly in patients that have characteristics of several different autoimmune diseases, the
602: 2026: 671:
of cells, which sparked the suggestion that the antigen recognized by autoantibodies might be important in ribosome
3903: 3519:
Lum, PY; Armour, CD; Stepaniants, SB; Cavet, G; Wolf, MK; Butler, JS; Hinshaw, JC; Garnier, P; et al. (2004).
777: 406:
In addition to single proteins, other protein complexes interact with the exosome. One of those is the cytoplasmic
166: 2642:"Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities" 3001:"Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase" 1234:
In archaea several exosome proteins are present in multiple copies, to form the full core of the exosome complex.
823: 2184:
Staals, RH; Bronkhorst, AW; Schilders, G; Slomovic, S; Schuster, G; Heck, AJ; Raijmakers, R; Pruijn, GJ (2010).
1464:
Chen, CY; Gherzi, R; Ong, SE; Chan, EL; Raijmakers, R; Pruijn, GJ; Stoecklin, G; Moroni, C; et al. (2001).
3728:
BΓΌttner, K; Wenig, K; Hopfner, KP (2006). "The exosome: a macromolecular cage for controlled RNA degradation".
2874:"Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathways" 187: 116: 3621:
Schilders, G; Pruijn, GJ (2008). "Chapter 11 Biochemical Studies of the Mammalian Exosome with Intact Cells".
56:
below. The channel through which RNA passes during degradation is visible at the center of the protein complex
710: 627: 510: 465: 521:. Several proteins that stabilize or destabilize mRNA molecules through binding to AU-rich elements in the 3898: 3888: 3737: 726: 3521:"Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes" 2601:"Structural basis of 3' end RNA recognition and exoribonucleolytic cleavage by an exosome RNase PH core" 776:, cerebellar atrophy, progressive microcephaly and profound global developmental delay, consistent with 679:
exosome proteins have become available and these have been used to develop line immunoassays (LIAs) and
457: 229: 1315:"The Exosome: A Conserved Eukaryotic RNA Processing Complex Containing Multiple 3β€²β†’5β€² Exoribonucleases" 3112: 3057: 2732:"Localization of AU-rich element-containing mRNA in cytoplasmic granules containing exosome subunits" 2041: 1169: 773: 686:
In these diseases, antibodies are mainly directed against two of the proteins of the complex, called
676: 170: 3742: 2238:"The human core exosome interacts with differentially localized processive RNases: hDIS3 and hDIS3L" 585:
Two core subunits of the archaeal exosome (Rrp41 and Rrp42), bound to a small RNA molecule (in red).
1134: 1099: 1064: 1029: 994: 959: 924: 889: 854: 769: 659: 453: 309: 261: 162: 143: 131:. The exosome has an exoribonucleolytic function, meaning it degrades RNA starting at one end (the 3476:
Jablonska, S; Blaszczyk, M (1998). "Scleromyositis: a scleroderma/polymyositis overlap syndrome".
479: 439:
Reaction diagrams for both hydrolytic (left) and phosphorolytic (right) 3' end degradation of RNA.
3835: 3763: 3550: 3501: 3081: 3030: 2981: 2581: 2530: 2449: 2418:
LaCava, J; Houseley, J; Saveanu, C; Petfalski, E; Thompson, E; Jacquier, A; Tollervey, D (2005).
2065: 1835: 1693: 1495: 1346: 655: 623: 200: 3853: 3827: 3798: 3755: 3716: 3673: 3644: 3634: 3600: 3542: 3493: 3458: 3423: 3372: 3337: 3284: 3249: 3214: 3183:
Gelpi, C; AlguerΓ³, A; Angeles Martinez, M; Vidal, S; Juarez, C; Rodriguez-Sanchez, JL (1991).
3165: 3130: 3073: 3022: 2973: 2938: 2903: 2854: 2805: 2753: 2712: 2663: 2622: 2573: 2522: 2441: 2400: 2351: 2316: 2267: 2215: 2163: 2114: 2057: 2007: 1966: 1925: 1876: 1827: 1791: 1745: 1685: 1650: 1640: 1598: 1547: 1487: 1446: 1395: 1338: 757: 595: 386:(in human). Like Rrp44, this protein is a hydrolytic exoribonuclease, but in this case of the 44: 31: 3819: 3788: 3747: 3706: 3698: 3665: 3626: 3590: 3582: 3532: 3485: 3450: 3413: 3403: 3364: 3327: 3317: 3276: 3241: 3204: 3196: 3157: 3120: 3065: 3012: 2965: 2930: 2893: 2885: 2844: 2836: 2795: 2787: 2743: 2702: 2694: 2653: 2612: 2563: 2514: 2482: 2431: 2390: 2382: 2343: 2306: 2298: 2257: 2249: 2205: 2197: 2153: 2145: 2104: 2096: 2049: 1997: 1956: 1915: 1907: 1866: 1819: 1781: 1773: 1735: 1727: 1677: 1632: 1588: 1580: 1537: 1529: 1477: 1436: 1426: 1385: 1377: 1328: 817: 706: 667:. Immunofluorescence using sera from these patients usually shows a typical staining of the 561: 224: 639: 557: 445: 419: 400: 337: 305: 301: 77: 3116: 3061: 2045: 3711: 3686: 3595: 3570: 3418: 3391: 3209: 3200: 3184: 2898: 2873: 2849: 2824: 2800: 2775: 2707: 2682: 2554: 2473: 2395: 2371:"Domain interactions within the Ski2/3/8 complex and between the Ski complex and Ski7p" 2370: 2262: 2237: 2210: 2185: 2158: 2109: 2084: 1920: 1895: 1740: 1715: 1593: 1566: 1364:
Allmang, C; Petfalski, E; Podtelejnikov, A; Mann, M; Tollervey, D; Mitchell, P (1999).
1319: 1270: 738: 619: 514: 356: 208: 192: 154: 151: 147: 139: 3868: 3863: 3858: 3630: 3537: 3520: 3304:"Autoantibodies directed to novel components of the PM/Scl complex, the human exosome" 2658: 2641: 2311: 2286: 1961: 1944: 1777: 1636: 1542: 1517: 1482: 1465: 1390: 1365: 1333: 1314: 581: 3882: 3751: 3569:
Vinters, H. V.; Chen, Z.; Zerres, K.; Ryan, M. M.; Nelson, S. F.; Jen, J. C. (2012).
3332: 3303: 3161: 2956:
Houseley J, LaCava J, Tollervey D (July 2006). "RNA-quality control by the exosome".
1823: 646:
of patients by a variety of assays. In the past, the most commonly used methods were
538: 506: 415: 124: 120: 3839: 3554: 3505: 2985: 2825:"MPP6 is an exosome-associated RNA-binding protein involved in 5.8S rRNA maturation" 2774:
Allmang, C; Kufel, J; Chanfreau, G; Mitchell, P; Petfalski, E; Tollervey, D (1999).
2585: 2534: 2453: 1839: 1565:
Evguenieva-Hackenberg, E; Walter, P; Hochleitner, E; Lottspeich, F; Klug, G (2003).
1499: 1350: 435: 3893: 3767: 3085: 3034: 2069: 1697: 1571: 1290: 745: 741: 672: 643: 635: 526: 292: 288: 108: 2469:"Erratum: Reconstitution, activities, and structure of the eukaryotic RNA exosome" 1366:"The yeast exosome and human PM-Scl are related complexes of 3' β†’ 5' exonucleases" 367: 3669: 3454: 3232:
Targoff, IN; Reichlin, M (1985). "Nucleolar localization of the PM-Scl antigen".
2617: 2600: 2420:"RNA degradation by the exosome is promoted by a nuclear polyadenylation complex" 2149: 3101:"RNA exosome depletion reveals transcription upstream of active human promoters" 2698: 1855:"Crystal structure of the tRNA processing enzyme RNase PH from Aquifex aeolicus" 1286: 722: 631: 574: 407: 371: 247: 97: 3793: 3776: 3185:"Identification of protein components reactive with anti-PM/Scl autoantibodies" 3017: 3000: 2791: 2568: 2549: 2487: 2468: 2436: 2419: 1731: 1264: 132: 2002: 1985: 1584: 1279: 1260: 461: 85: 3702: 2302: 548:
Although most cells have other enzymes that can degrade RNA, either from the
3125: 3100: 2683:"A genomic screen in yeast reveals novel aspects of nonstop mRNA metabolism" 2347: 2134:"The exosome subunit Rrp44 plays a direct role in RNA substrate recognition" 1218: 1175: 1140: 1105: 1070: 1035: 1000: 965: 930: 895: 860: 714: 668: 591: 534: 502: 362: 297: 265: 161:
function by blocking the activity of the exosome. In addition, mutations in
128: 112: 104: 48: 39: 3864:
Structure of an archaeal exosome bound to RNA at the RCSB Protein Data Bank
3831: 3802: 3759: 3720: 3677: 3648: 3604: 3546: 3462: 3427: 3376: 3341: 3288: 3245: 3169: 3134: 3077: 3026: 2977: 2942: 2907: 2858: 2809: 2757: 2748: 2731: 2716: 2667: 2626: 2577: 2526: 2445: 2404: 2355: 2271: 2253: 2219: 2201: 2167: 2118: 2061: 2011: 1970: 1929: 1880: 1871: 1854: 1831: 1795: 1749: 1689: 1654: 1602: 1551: 1491: 1450: 1431: 1414: 1399: 1381: 553: 549: 522: 449: 313: 3623:
RNA Turnover in Eukaryotes: Nucleases, Pathways and Analysis of mRNA Decay
3497: 3253: 3218: 2320: 2100: 1342: 360:"Ribbon view" of the partial structure of the yeast exosome subunit Rrp6, 3869:
Structure of the yeast exosome protein Rrp6 at the RCSB Protein Data Bank
3823: 3392:"Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen" 3390:
Mahler, M; Raijmakers, R; DΓ€hnrich, C; BlΓΌthner, M; Fritzler, MJ (2005).
2840: 2550:"Reconstitution, activities, and structure of the eukaryotic RNA exosome" 1466:"AU binding proteins recruit the exosome to degrade ARE-containing mRNAs" 718: 565: 556:
of the RNA, the exosome complex is essential for cell survival. When the
411: 284: 272: 241: 93: 3069: 2386: 2186:"Dis3-like 1: a novel exoribonuclease associated with the human exosome" 2053: 1911: 1313:
Mitchell, P; Petfalski, E; Shevchenko, A; Mann, M; Tollervey, D (1997).
3873: 3489: 2934: 2889: 1786: 1441: 695: 560:
of exosome proteins is artificially reduced or stopped, for example by
387: 333: 199:, which had been identified as an autoantigen in patients with certain 119:
specific to these cell compartments. Substrates of the exosome include
89: 73: 3368: 3280: 2287:"Comparative sequence analysis of ribonucleases HII, III, II PH and D" 1629:
Cell and molecular biology of the exosome: how to make or break an RNA
1533: 517:
pathways. In alternative fashion, mRNAs are degraded as part of their
2518: 1631:. International Review of Cytology. Vol. 251. pp. 159–208. 1513: 1211: 749: 651: 542: 346: 158: 17: 3586: 2969: 1681: 3777:"The Exosome and the Proteasome: Nano-Compartments for Degradation" 3408: 781: 3874:
3D macromolecular structures of exosomes at the EM Data Bank(EMDB)
3322: 3099:
Preker P, P; Nielsen, J; Kammler, S; et al. (December 2008).
753: 699: 630:, an autoimmune disease in which patients have symptoms from both 580: 530: 478: 434: 246: 223: 182: 84:(ribonucleic acid) molecules. Exosome complexes are found in both 38: 1207: 529:, the exosome is required for the correct processing of several 518: 350: 280: 2999:
Wyers F, F; Rougemaille, M; Badis, G; et al. (June 2005).
260:
Located on top of this ring are three proteins that have an S1
3859:
Structure of an archaeal exosome at the RCSB Protein Data Bank
2776:"Functions of the exosome in rRNA, snoRNA and snRNA synthesis" 541:(the first identified function of the exosome) and of several 317: 81: 2025:
Lebreton, A; Tomecki, R; Dziembowski, A; SΓ©raphin, B (2008).
1627:
Schilders, G; Van Dijk, E; Raijmakers, R; Pruijn, GJ (2006).
3854:
Structure of the human exosome at the RCSB Protein Data Bank
752:. It is one of the most successful drugs for treating solid 698:, derived from the PM/Scl-100 protein, as the antigen in an 271:
This ring structure is very similar to that of the proteins
2823:
Schilders, G; Raijmakers, R; Raats, JM; Pruijn, GJ (2005).
1252:
Contributes to the ribonucleolytic activity of the complex.
626:. These autoantibodies are mainly found in people with the 3625:. Methods in Enzymology. Vol. 448. pp. 211–226. 279:. In bacteria, the protein RNase PH, which is involved in 3148:
J.E. Pope, JE (2002). "Scleroderma overlap syndromes".
2083:
Schneider, C; Leung, E; Brown, J; Tollervey, D (2009).
1894:
Harlow, LS; Kadziola, A; Jensen, KF; Larsen, S (2004).
2027:"Endonucleolytic RNA cleavage by a eukaryotic exosome" 3687:"The exosome and RNA quality control in the nucleus" 1567:"An exosome-like complex in Sulfolobus solfataricus" 448:, meaning that it degrades RNA molecules from their 525:of mRNAs interact with the exosome complex. In the 1293:, that also contains an RNA binding ring structure 737:The exosome has been shown to be inhibited by the 138:Several proteins in the exosome are the target of 3810:Pruijn, GJ (2005). "Doughnuts dealing with RNA". 2132:Schneider, C; Anderson, JT; Tollervey, D (2007). 1716:"A view to a kill: structure of the RNA exosome" 2872:van Dijk, EL; Schilders, G; Pruijn, GJ (2007). 2500: 2498: 1282:, the main protein degrading machinery of cells 497:The exosome is involved in the degradation and 378:The second common associated protein is called 1709: 1707: 418:, which contains both RNA helicase (Mtr4) and 264:domain (RBD). Two proteins in addition have a 1415:"Three novel components of the human exosome" 505:of cells, it is involved in the turn-over of 8: 1984:Lin-Chao, S; Chiou, NT; Schuster, G (2007). 43:"Ribbon view" of the human exosome complex. 332:, a hydrolytic RNase, which belongs to the 232:of the human exosome complex. See the full 2681:Wilson, MA; Meaux, S; Van Hoof, A (2007). 2231: 2229: 1943:Symmons, MF; Jones, GH; Luisi, BF (2000). 1308: 1306: 791: 3812:Nature Structural & Molecular Biology 3792: 3741: 3710: 3594: 3536: 3417: 3407: 3331: 3321: 3208: 3124: 3016: 2897: 2848: 2799: 2747: 2706: 2657: 2616: 2567: 2507:Nature Structural & Molecular Biology 2486: 2435: 2394: 2310: 2261: 2209: 2179: 2177: 2157: 2108: 2001: 1960: 1919: 1870: 1853:Ishii, R; Nureki, O; Yokoyama, S (2003). 1785: 1739: 1670:Nature Structural & Molecular Biology 1592: 1541: 1481: 1440: 1430: 1389: 1332: 683:(ELISAs) for detecting these antibodies. 501:of a wide variety of RNA species. In the 2369:Wang, L; Lewis, MS; Johnson, AW (2005). 642:. Autoantibodies can be detected in the 355: 2769: 2767: 2548:Liu, Q; Greimann, JC; Lima, CD (2006). 2467:Liu, Q; Greimann, JC; Lima, CD (2007). 1302: 181:The exosome was first discovered as an 2640:LeJeune, F; Li, X; Maquat, LE (2003). 460:. The hydrolytic enzymes use water to 80:capable of degrading various types of 1622: 1620: 1618: 1616: 1614: 1612: 618:The exosome complex is the target of 485: 253: 233: 53: 7: 3189:Clinical and Experimental Immunology 2730:Lin, WJ; Duffy, A; Chen, CY (2007). 3201:10.1111/j.1365-2249.1990.tb05291.x 681:enzyme linked immunosorbent assays 25: 27:Protein complex that degrades RNA 3752:10.1111/j.1365-2958.2006.05331.x 3396:Arthritis Research & Therapy 3309:Arthritis Research & Therapy 3162:10.1097/00002281-200211000-00013 2336:European Journal of Cell Biology 1824:10.1111/j.1365-2958.2006.05393.x 1263: 1247: 1238: 1229: 349:) and the other in the nucleus ( 3775:Lorentzen, E; Conti, E (2006). 3150:Current Opinion in Rheumatology 2736:Journal of Biological Chemistry 2599:Lorentzen, E; Conti, E (2005). 1859:Journal of Biological Chemistry 1516:; Wolf, YI; Aravind, L (2001). 1419:Journal of Biological Chemistry 690:(the RNase D like protein) and 312:to remove nucleotides from the 100:carries out similar functions. 3685:Vanacova, S; Stefl, R (2007). 1714:Shen, V; Kiledjian, M (2006). 1: 3631:10.1016/S0076-6879(08)02611-6 3538:10.1016/S0092-8674(03)01035-3 2659:10.1016/S1097-2765(03)00349-6 1990:Journal of Biomedical Science 1962:10.1016/S0969-2126(00)00521-9 1778:10.1016/S0022-2836(02)00947-6 1637:10.1016/S0074-7696(06)51005-8 1483:10.1016/S0092-8674(01)00578-5 1334:10.1016/S0092-8674(00)80432-8 185:in 1997 in the budding yeast 96:a simpler complex called the 3670:10.1016/j.bbagrm.2007.12.008 3455:10.1016/j.autrev.2007.01.013 2618:10.1016/j.molcel.2005.10.020 2150:10.1016/j.molcel.2007.06.006 1766:Journal of Molecular Biology 1182: 1147: 1112: 1077: 1042: 1007: 972: 937: 902: 867: 832: 603:cryptic unstable transcripts 533:RNA molecules. Finally, the 296:complexes are thought to be 204: 2699:10.1534/genetics.107.073205 729:or immunomodulating drugs. 3920: 3794:10.1016/j.cell.2006.05.002 3357:Arthritis & Rheumatism 3269:Arthritis & Rheumatism 3234:Arthritis & Rheumatism 3018:10.1016/j.cell.2005.04.030 2569:10.1016/j.cell.2006.10.037 2488:10.1016/j.cell.2007.09.019 2437:10.1016/j.cell.2005.04.029 1732:10.1016/j.cell.2006.11.035 778:pontocerebellar hypoplasia 167:pontocerebellar hypoplasia 142:in patients with specific 29: 2003:10.1007/s11373-007-9178-y 1585:10.1038/sj.embor.embor929 622:in patients with various 466:nucleotide monophosphates 228:Top and side view of the 3703:10.1038/sj.embor.7401005 2958:Nat. Rev. Mol. Cell Biol 2792:10.1093/emboj/18.19.5399 1289:, a complex involved in 464:these bonds – releasing 410:, which includes an RNA 308:, meaning that they use 188:Saccharomyces cerevisiae 68:, often just called the 30:Not to be confused with 3126:10.1126/science.1164096 2348:10.1078/0171-9335-00385 1370:Genes & Development 772:cause infantile spinal 628:PM/Scl overlap syndrome 511:nonsense mediated decay 458:nucleotide diphosphates 148:PM/Scl overlap syndrome 3730:Molecular Microbiology 3246:10.1002/art.1780280221 2829:Nucleic Acids Research 2749:10.1074/jbc.M702281200 2303:10.1093/nar/25.16.3187 2291:Nucleic Acids Research 2254:10.1038/emboj.2010.121 2202:10.1038/emboj.2010.122 2089:Nucleic Acids Research 1872:10.1074/jbc.M300639200 1812:Molecular Microbiology 1432:10.1074/jbc.M007603200 1382:10.1101/gad.13.16.2148 764:Neurological disorders 648:double immunodiffusion 586: 523:3' untranslated region 489: 440: 375: 266:K-homology (KH) domain 257: 237: 127:, and many species of 57: 3478:Clinical Rheumatology 744:, a drug used in the 584: 482: 438: 359: 336:family of hydrolytic 250: 227: 111:, and especially the 42: 3824:10.1038/nsmb0705-562 3658:Biochim Biophys Acta 3443:Autoimmunity Reviews 774:motor neuron disease 758:molecular biological 711:Raynaud's phenomenon 543:small nucleolar RNAs 454:phosphodiester bonds 171:motor neuron disease 3117:2008Sci...322.1851P 3070:10.1038/nature07747 3062:2009Natur.457.1038N 2923:Biochem. Soc. Trans 2387:10.1261/rna.2060405 2101:10.1093/nar/gkn1020 2054:10.1038/nature07480 2046:2008Natur.456..993L 1912:10.1110/ps.03477004 770:exosome component 3 660:immunoprecipitation 624:autoimmune diseases 394:Regulatory proteins 324:Associated proteins 310:inorganic phosphate 300:related and have a 203:years earlier (see 201:autoimmune diseases 163:exosome component 3 144:autoimmune diseases 3490:10.1007/BF01451281 2935:10.1042/BST0300150 2890:10.1261/rna.575107 2841:10.1093/nar/gki982 658:on HEp-2 cells or 656:immunofluorescence 587: 490: 488:for a full legend. 441: 431:Enzymatic function 376: 258: 238: 58: 3904:Protein complexes 3369:10.1002/art.22710 3281:10.1002/art.20056 3056:(7232): 1038–42. 2297:(16): 3187–3195. 2285:Mian, IS (1997). 1865:(34): 32397–404. 1534:10.1101/gr.162001 1225: 1224: 782:PCH1B; MIM 614678 727:immunosuppressive 707:clinical symptoms 675:. More recently, 596:protein synthesis 422:(Trf4) activity. 230:crystal structure 32:Exosome (vesicle) 16:(Redirected from 3911: 3843: 3806: 3796: 3771: 3745: 3736:(6): 1372–1379. 3724: 3714: 3681: 3652: 3609: 3608: 3598: 3565: 3559: 3558: 3540: 3516: 3510: 3509: 3473: 3467: 3466: 3438: 3432: 3431: 3421: 3411: 3387: 3381: 3380: 3352: 3346: 3345: 3335: 3325: 3299: 3293: 3292: 3264: 3258: 3257: 3229: 3223: 3222: 3212: 3180: 3174: 3173: 3145: 3139: 3138: 3128: 3111:(5909): 1851–4. 3096: 3090: 3089: 3045: 3039: 3038: 3020: 2996: 2990: 2989: 2953: 2947: 2946: 2918: 2912: 2911: 2901: 2869: 2863: 2862: 2852: 2835:(21): 6795–804. 2820: 2814: 2813: 2803: 2786:(19): 5399–410. 2771: 2762: 2761: 2751: 2742:(27): 19958–68. 2727: 2721: 2720: 2710: 2678: 2672: 2671: 2661: 2637: 2631: 2630: 2620: 2596: 2590: 2589: 2571: 2545: 2539: 2538: 2519:10.1038/nsmb1184 2502: 2493: 2492: 2490: 2464: 2458: 2457: 2439: 2415: 2409: 2408: 2398: 2366: 2360: 2359: 2331: 2325: 2324: 2314: 2282: 2276: 2275: 2265: 2242:The EMBO Journal 2233: 2224: 2223: 2213: 2190:The EMBO Journal 2181: 2172: 2171: 2161: 2129: 2123: 2122: 2112: 2080: 2074: 2073: 2031: 2022: 2016: 2015: 2005: 1981: 1975: 1974: 1964: 1940: 1934: 1933: 1923: 1891: 1885: 1884: 1874: 1850: 1844: 1843: 1806: 1800: 1799: 1789: 1760: 1754: 1753: 1743: 1711: 1702: 1701: 1665: 1659: 1658: 1624: 1607: 1606: 1596: 1562: 1556: 1555: 1545: 1510: 1504: 1503: 1485: 1461: 1455: 1454: 1444: 1434: 1410: 1404: 1403: 1393: 1361: 1355: 1354: 1336: 1310: 1273: 1268: 1267: 1251: 1242: 1233: 792: 788:List of subunits 733:Cancer treatment 562:RNA interference 365: 338:exoribonucleases 306:exoribonucleases 191:, an often-used 146:(especially the 51: 21: 3919: 3918: 3914: 3913: 3912: 3910: 3909: 3908: 3879: 3878: 3850: 3809: 3774: 3743:10.1.1.232.6756 3727: 3684: 3655: 3641: 3620: 3617: 3615:Further reading 3612: 3587:10.1038/ng.2254 3575:Nature Genetics 3567: 3566: 3562: 3518: 3517: 3513: 3475: 3474: 3470: 3440: 3439: 3435: 3389: 3388: 3384: 3354: 3353: 3349: 3301: 3300: 3296: 3266: 3265: 3261: 3231: 3230: 3226: 3182: 3181: 3177: 3147: 3146: 3142: 3098: 3097: 3093: 3047: 3046: 3042: 2998: 2997: 2993: 2970:10.1038/nrm1964 2955: 2954: 2950: 2920: 2919: 2915: 2871: 2870: 2866: 2822: 2821: 2817: 2773: 2772: 2765: 2729: 2728: 2724: 2680: 2679: 2675: 2639: 2638: 2634: 2598: 2597: 2593: 2547: 2546: 2542: 2504: 2503: 2496: 2466: 2465: 2461: 2417: 2416: 2412: 2381:(8): 1291–302. 2368: 2367: 2363: 2333: 2332: 2328: 2284: 2283: 2279: 2248:(14): 2342–57. 2235: 2234: 2227: 2196:(14): 2358–67. 2183: 2182: 2175: 2131: 2130: 2126: 2082: 2081: 2077: 2040:(7224): 993–6. 2029: 2024: 2023: 2019: 1983: 1982: 1978: 1955:(11): 1215–26. 1942: 1941: 1937: 1900:Protein Science 1893: 1892: 1888: 1852: 1851: 1847: 1808: 1807: 1803: 1762: 1761: 1757: 1713: 1712: 1705: 1682:10.1038/nsmb952 1667: 1666: 1662: 1647: 1626: 1625: 1610: 1564: 1563: 1559: 1522:Genome Research 1512: 1511: 1507: 1463: 1462: 1458: 1412: 1411: 1407: 1376:(16): 2148–58. 1363: 1362: 1358: 1312: 1311: 1304: 1300: 1269: 1262: 1259: 1246: 1237: 1228: 790: 766: 735: 640:dermatomyositis 616: 611: 519:normal turnover 495: 446:exoribonuclease 433: 428: 420:polyadenylation 401:AU-rich element 396: 361: 326: 302:common ancestor 222: 217: 179: 62:exosome complex 47: 35: 28: 23: 22: 15: 12: 11: 5: 3917: 3915: 3907: 3906: 3901: 3896: 3891: 3881: 3880: 3877: 3876: 3871: 3866: 3861: 3856: 3849: 3848:External links 3846: 3845: 3844: 3818:(7): 562–564. 3807: 3787:(4): 651–654. 3772: 3725: 3697:(7): 651–657. 3682: 3664:(4): 239–246. 3653: 3639: 3616: 3613: 3611: 3610: 3581:(6): 704–708. 3560: 3511: 3468: 3433: 3409:10.1186/ar1729 3402:(3): R704–13. 3382: 3363:(7): 2449–54. 3347: 3294: 3259: 3224: 3175: 3140: 3091: 3040: 2991: 2948: 2913: 2884:(7): 1027–35. 2864: 2815: 2763: 2722: 2673: 2646:Molecular Cell 2632: 2605:Molecular Cell 2591: 2562:(6): 1223–37. 2540: 2494: 2481:(1): 188–189. 2459: 2410: 2361: 2326: 2277: 2225: 2173: 2138:Molecular Cell 2124: 2095:(4): 1127–40. 2075: 2017: 1976: 1935: 1886: 1845: 1818:(4): 1076–89. 1801: 1755: 1703: 1660: 1645: 1608: 1557: 1505: 1456: 1425:(9): 6177–84. 1405: 1356: 1327:(4): 457–466. 1301: 1299: 1296: 1295: 1294: 1283: 1275: 1274: 1271:Biology portal 1258: 1255: 1254: 1253: 1244: 1235: 1223: 1222: 1215: 1205: 1202: 1199: 1196: 1190: 1187: 1184: 1180: 1179: 1172: 1167: 1164: 1161: 1158: 1155: 1152: 1149: 1145: 1144: 1137: 1132: 1129: 1126: 1123: 1120: 1117: 1114: 1110: 1109: 1102: 1097: 1094: 1091: 1088: 1085: 1082: 1079: 1075: 1074: 1067: 1062: 1059: 1056: 1053: 1050: 1047: 1044: 1040: 1039: 1032: 1027: 1024: 1021: 1018: 1015: 1012: 1009: 1005: 1004: 997: 992: 989: 986: 983: 980: 977: 974: 970: 969: 962: 957: 954: 951: 948: 945: 942: 939: 935: 934: 927: 922: 919: 916: 913: 910: 907: 904: 900: 899: 892: 887: 884: 881: 878: 875: 872: 869: 865: 864: 857: 852: 849: 846: 843: 840: 837: 834: 830: 829: 826: 821: 815: 812: 805: 802: 799: 796: 789: 786: 765: 762: 739:antimetabolite 734: 731: 665:PM/Scl complex 620:autoantibodies 615: 612: 610: 607: 515:non-stop decay 494: 491: 432: 429: 427: 424: 395: 392: 382:(in yeast) or 325: 322: 298:evolutionarily 221: 218: 216: 213: 197:PM/Scl complex 193:model organism 178: 175: 155:chemotherapies 140:autoantibodies 76:intracellular 66:PM/Scl complex 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 3916: 3905: 3902: 3900: 3899:Ribonucleases 3897: 3895: 3892: 3890: 3889:Nucleic acids 3887: 3886: 3884: 3875: 3872: 3870: 3867: 3865: 3862: 3860: 3857: 3855: 3852: 3851: 3847: 3841: 3837: 3833: 3829: 3825: 3821: 3817: 3813: 3808: 3804: 3800: 3795: 3790: 3786: 3782: 3778: 3773: 3769: 3765: 3761: 3757: 3753: 3749: 3744: 3739: 3735: 3731: 3726: 3722: 3718: 3713: 3708: 3704: 3700: 3696: 3692: 3688: 3683: 3679: 3675: 3671: 3667: 3663: 3659: 3654: 3650: 3646: 3642: 3640:9780123743787 3636: 3632: 3628: 3624: 3619: 3618: 3614: 3606: 3602: 3597: 3592: 3588: 3584: 3580: 3576: 3572: 3564: 3561: 3556: 3552: 3548: 3544: 3539: 3534: 3531:(1): 121–37. 3530: 3526: 3522: 3515: 3512: 3507: 3503: 3499: 3495: 3491: 3487: 3483: 3479: 3472: 3469: 3464: 3460: 3456: 3452: 3448: 3444: 3437: 3434: 3429: 3425: 3420: 3415: 3410: 3405: 3401: 3397: 3393: 3386: 3383: 3378: 3374: 3370: 3366: 3362: 3358: 3351: 3348: 3343: 3339: 3334: 3329: 3324: 3323:10.1186/ar389 3319: 3315: 3311: 3310: 3305: 3298: 3295: 3290: 3286: 3282: 3278: 3274: 3270: 3263: 3260: 3255: 3251: 3247: 3243: 3240:(2): 226–30. 3239: 3235: 3228: 3225: 3220: 3216: 3211: 3206: 3202: 3198: 3194: 3190: 3186: 3179: 3176: 3171: 3167: 3163: 3159: 3156:(6): 704–10. 3155: 3151: 3144: 3141: 3136: 3132: 3127: 3122: 3118: 3114: 3110: 3106: 3102: 3095: 3092: 3087: 3083: 3079: 3075: 3071: 3067: 3063: 3059: 3055: 3051: 3044: 3041: 3036: 3032: 3028: 3024: 3019: 3014: 3011:(5): 725–37. 3010: 3006: 3002: 2995: 2992: 2987: 2983: 2979: 2975: 2971: 2967: 2964:(7): 529–39. 2963: 2959: 2952: 2949: 2944: 2940: 2936: 2932: 2928: 2924: 2917: 2914: 2909: 2905: 2900: 2895: 2891: 2887: 2883: 2879: 2875: 2868: 2865: 2860: 2856: 2851: 2846: 2842: 2838: 2834: 2830: 2826: 2819: 2816: 2811: 2807: 2802: 2797: 2793: 2789: 2785: 2781: 2777: 2770: 2768: 2764: 2759: 2755: 2750: 2745: 2741: 2737: 2733: 2726: 2723: 2718: 2714: 2709: 2704: 2700: 2696: 2693:(2): 773–84. 2692: 2688: 2684: 2677: 2674: 2669: 2665: 2660: 2655: 2652:(3): 675–87. 2651: 2647: 2643: 2636: 2633: 2628: 2624: 2619: 2614: 2611:(3): 473–81. 2610: 2606: 2602: 2595: 2592: 2587: 2583: 2579: 2575: 2570: 2565: 2561: 2557: 2556: 2551: 2544: 2541: 2536: 2532: 2528: 2524: 2520: 2516: 2512: 2508: 2501: 2499: 2495: 2489: 2484: 2480: 2476: 2475: 2470: 2463: 2460: 2455: 2451: 2447: 2443: 2438: 2433: 2430:(5): 713–24. 2429: 2425: 2421: 2414: 2411: 2406: 2402: 2397: 2392: 2388: 2384: 2380: 2376: 2372: 2365: 2362: 2357: 2353: 2349: 2345: 2342:(5): 175–83. 2341: 2337: 2330: 2327: 2322: 2318: 2313: 2308: 2304: 2300: 2296: 2292: 2288: 2281: 2278: 2273: 2269: 2264: 2259: 2255: 2251: 2247: 2243: 2239: 2232: 2230: 2226: 2221: 2217: 2212: 2207: 2203: 2199: 2195: 2191: 2187: 2180: 2178: 2174: 2169: 2165: 2160: 2155: 2151: 2147: 2144:(2): 324–31. 2143: 2139: 2135: 2128: 2125: 2120: 2116: 2111: 2106: 2102: 2098: 2094: 2090: 2086: 2079: 2076: 2071: 2067: 2063: 2059: 2055: 2051: 2047: 2043: 2039: 2035: 2028: 2021: 2018: 2013: 2009: 2004: 1999: 1996:(4): 523–32. 1995: 1991: 1987: 1980: 1977: 1972: 1968: 1963: 1958: 1954: 1950: 1946: 1939: 1936: 1931: 1927: 1922: 1917: 1913: 1909: 1906:(3): 668–77. 1905: 1901: 1897: 1890: 1887: 1882: 1878: 1873: 1868: 1864: 1860: 1856: 1849: 1846: 1841: 1837: 1833: 1829: 1825: 1821: 1817: 1813: 1805: 1802: 1797: 1793: 1788: 1783: 1779: 1775: 1772:(4): 653–63. 1771: 1767: 1759: 1756: 1751: 1747: 1742: 1737: 1733: 1729: 1726:(6): 1093–5. 1725: 1721: 1717: 1710: 1708: 1704: 1699: 1695: 1691: 1687: 1683: 1679: 1676:(7): 575–81. 1675: 1671: 1664: 1661: 1656: 1652: 1648: 1646:9780123646552 1642: 1638: 1634: 1630: 1623: 1621: 1619: 1617: 1615: 1613: 1609: 1604: 1600: 1595: 1590: 1586: 1582: 1579:(9): 889–93. 1578: 1574: 1573: 1568: 1561: 1558: 1553: 1549: 1544: 1539: 1535: 1531: 1528:(2): 240–52. 1527: 1523: 1519: 1515: 1509: 1506: 1501: 1497: 1493: 1489: 1484: 1479: 1476:(4): 451–64. 1475: 1471: 1467: 1460: 1457: 1452: 1448: 1443: 1438: 1433: 1428: 1424: 1420: 1416: 1409: 1406: 1401: 1397: 1392: 1387: 1383: 1379: 1375: 1371: 1367: 1360: 1357: 1352: 1348: 1344: 1340: 1335: 1330: 1326: 1322: 1321: 1316: 1309: 1307: 1303: 1297: 1292: 1288: 1284: 1281: 1277: 1276: 1272: 1266: 1261: 1256: 1250: 1249: 1245: 1241: 1240: 1236: 1232: 1231: 1227: 1226: 1221: 1220: 1216: 1214: 1213: 1209: 1206: 1203: 1200: 1197: 1195: 1191: 1188: 1185: 1181: 1178: 1177: 1173: 1171: 1168: 1165: 1162: 1159: 1156: 1153: 1150: 1146: 1143: 1142: 1138: 1136: 1133: 1130: 1127: 1124: 1121: 1118: 1115: 1111: 1108: 1107: 1103: 1101: 1098: 1095: 1092: 1089: 1086: 1083: 1080: 1076: 1073: 1072: 1068: 1066: 1063: 1060: 1057: 1054: 1051: 1048: 1045: 1041: 1038: 1037: 1033: 1031: 1028: 1025: 1022: 1019: 1016: 1013: 1010: 1006: 1003: 1002: 998: 996: 993: 990: 987: 984: 981: 978: 975: 971: 968: 967: 963: 961: 958: 955: 952: 949: 946: 943: 940: 936: 933: 932: 928: 926: 923: 920: 917: 914: 911: 908: 905: 901: 898: 897: 893: 891: 888: 885: 882: 879: 876: 873: 870: 866: 863: 862: 858: 856: 853: 850: 847: 844: 841: 838: 835: 831: 827: 825: 822: 819: 816: 813: 810: 809:S. cerevisiae 806: 803: 800: 798:General name 797: 794: 793: 787: 785: 783: 779: 775: 771: 768:Mutations in 763: 761: 759: 755: 751: 747: 743: 740: 732: 730: 728: 724: 720: 716: 712: 708: 703: 701: 697: 693: 689: 684: 682: 678: 674: 670: 666: 661: 657: 653: 649: 645: 641: 637: 633: 629: 625: 621: 613: 608: 606: 604: 599: 597: 593: 583: 579: 577: 576: 572:, called the 571: 567: 563: 559: 555: 551: 546: 544: 540: 539:ribosomal RNA 536: 532: 531:small nuclear 528: 524: 520: 516: 512: 508: 507:messenger RNA 504: 500: 492: 487: 481: 477: 473: 469: 467: 463: 459: 455: 451: 447: 437: 430: 425: 423: 421: 417: 416:TRAMP complex 413: 409: 404: 402: 393: 391: 389: 385: 381: 373: 369: 364: 358: 354: 352: 348: 343: 339: 335: 331: 323: 321: 319: 315: 311: 307: 303: 299: 294: 290: 286: 282: 278: 274: 269: 267: 263: 255: 249: 245: 243: 235: 231: 226: 220:Core proteins 219: 214: 212: 210: 206: 202: 198: 194: 190: 189: 184: 176: 174: 172: 168: 164: 160: 156: 153: 152:antimetabolic 149: 145: 141: 136: 134: 130: 126: 125:ribosomal RNA 122: 121:messenger RNA 118: 114: 110: 106: 101: 99: 95: 91: 87: 83: 79: 75: 72:) is a multi- 71: 67: 63: 55: 50: 46: 41: 37: 33: 19: 3815: 3811: 3784: 3780: 3733: 3729: 3694: 3691:EMBO Reports 3690: 3661: 3657: 3622: 3578: 3574: 3563: 3528: 3524: 3514: 3484:(6): 465–7. 3481: 3477: 3471: 3449:(7): 432–7. 3446: 3442: 3436: 3399: 3395: 3385: 3360: 3356: 3350: 3316:(2): 134–8. 3313: 3307: 3297: 3275:(2): 565–9. 3272: 3268: 3262: 3237: 3233: 3227: 3195:(1): 59–64. 3192: 3188: 3178: 3153: 3149: 3143: 3108: 3104: 3094: 3053: 3049: 3043: 3008: 3004: 2994: 2961: 2957: 2951: 2929:(2): 150–5. 2926: 2922: 2916: 2881: 2877: 2867: 2832: 2828: 2818: 2783: 2780:EMBO Journal 2779: 2739: 2735: 2725: 2690: 2686: 2676: 2649: 2645: 2635: 2608: 2604: 2594: 2559: 2553: 2543: 2513:(1): 15–22. 2510: 2506: 2478: 2472: 2462: 2427: 2423: 2413: 2378: 2374: 2364: 2339: 2335: 2329: 2294: 2290: 2280: 2245: 2241: 2193: 2189: 2141: 2137: 2127: 2092: 2088: 2078: 2037: 2033: 2020: 1993: 1989: 1979: 1952: 1948: 1938: 1903: 1899: 1889: 1862: 1858: 1848: 1815: 1811: 1804: 1769: 1765: 1758: 1723: 1719: 1673: 1669: 1663: 1628: 1576: 1572:EMBO Reports 1570: 1560: 1525: 1521: 1508: 1473: 1469: 1459: 1422: 1418: 1408: 1373: 1369: 1359: 1324: 1318: 1291:RNA splicing 1248: 1239: 1230: 1217: 1210: 1198:Rrp44p/Dis3p 1193: 1174: 1139: 1104: 1069: 1034: 999: 964: 950:Rrp41p/Ski6p 929: 894: 859: 808: 767: 746:chemotherapy 742:fluorouracil 736: 704: 691: 687: 685: 664: 636:polymyositis 617: 614:Autoimmunity 600: 588: 573: 552:or from the 547: 496: 474: 470: 456:– releasing 442: 405: 397: 383: 379: 377: 341: 329: 327: 293:mitochondria 289:chloroplasts 270: 259: 239: 196: 186: 180: 137: 102: 69: 65: 61: 59: 36: 1787:2066/186665 1442:2066/186951 1287:spliceosome 845:Csl4p/Ski4p 828:Yeast gene 723:scleroderma 677:recombinant 650:using calf 634:and either 632:scleroderma 575:degradosome 408:Ski complex 370:in red and 320:molecules. 262:RNA binding 209:genome data 169:and spinal 150:) and some 98:degradosome 92:, while in 3883:Categories 1514:Koonin, EV 1298:References 1280:proteasome 1157:PM/Scl-100 824:Human gene 688:PM/Scl-100 654:extracts, 558:expression 499:processing 493:Substrates 384:PM/Scl-100 374:in yellow. 129:small RNAs 117:substrates 88:cells and 86:eukaryotic 3738:CiteSeerX 1949:Structure 1122:PM/Scl-75 909:S1/KH RBD 874:S1/KH RBD 780:type 1B ( 715:arthritis 692:PM/Scl-75 673:synthesis 669:nucleolus 592:ribosomes 535:nucleolus 503:cytoplasm 462:hydrolyse 368:Ξ±-helices 215:Structure 177:Discovery 113:nucleolus 105:cytoplasm 3840:43218090 3832:15999107 3803:16713559 3760:16968219 3721:17603538 3678:18211833 3649:19111178 3605:22544365 3555:11922219 3547:14718172 3506:39237322 3463:17643929 3428:15899056 3377:17599775 3342:11879549 3289:14872500 3170:12410095 3135:19056938 3078:19169244 3027:15935759 2986:22499032 2978:16829983 2943:12035760 2908:17545563 2859:16396833 2810:10508172 2758:17470429 2717:17660569 2687:Genetics 2668:14527413 2627:16285928 2586:62785677 2578:17174896 2535:24691764 2527:17173052 2454:14898055 2446:15935758 2405:16043509 2356:15346807 2272:20531386 2220:20531389 2168:17643380 2119:19129231 2062:19060886 2012:17514363 1971:11080643 1930:14767080 1881:12746447 1840:27114625 1832:17078816 1796:12419256 1750:17174886 1690:15951817 1655:16939780 1603:12947419 1552:11157787 1500:14817671 1492:11719186 1451:11110791 1400:10465791 1351:16035676 1257:See also 1119:RNase PH 1084:RNase PH 1049:RNase PH 1014:RNase PH 979:RNase PH 944:RNase PH 814:Archaea 801:Domains 719:myositis 566:Bacteria 426:Function 412:helicase 372:Ξ²-sheets 287:and the 285:bacteria 273:RNase PH 242:RNase PH 94:bacteria 52:See the 3768:6872855 3712:1905902 3596:3366034 3498:9890673 3419:1174964 3254:3918546 3219:2199097 3210:1535032 3113:Bibcode 3105:Science 3086:4329373 3058:Bibcode 3035:1390706 2899:1894934 2850:1310903 2801:1171609 2708:2034642 2396:1370812 2321:9241229 2263:2910271 2211:2910272 2159:7610968 2110:2651783 2070:1808371 2042:Bibcode 1921:2286726 1741:1986773 1698:2003922 1594:1326366 1343:9390555 1219:YOL021C 1204:105–113 1194:Dis3L1 1189:RNase R 1176:YOR001W 1170:EXOSC10 1154:RNase D 1141:YDR280W 1128:(Rrp42) 1106:YCR035C 1093:(Rrp42) 1071:YDL111C 1036:YGR158C 1023:(Rrp41) 1001:YGR095C 988:(Rrp41) 966:YGR195W 931:YOL142W 896:YHR069C 861:YNL232W 807:Yeast ( 795:Legend 696:peptide 609:Disease 527:nucleus 388:RNase D 334:RNase R 109:nucleus 90:archaea 78:complex 74:protein 70:exosome 3838:  3830:  3801:  3766:  3758:  3740:  3719:  3709:  3676:  3647:  3637:  3603:  3593:  3553:  3545:  3504:  3496:  3461:  3426:  3416:  3375:  3340:  3330:  3287:  3252:  3217:  3207:  3168:  3133:  3084:  3076:  3050:Nature 3033:  3025:  2984:  2976:  2941:  2906:  2896:  2857:  2847:  2808:  2798:  2756:  2715:  2705:  2666:  2625:  2584:  2576:  2533:  2525:  2452:  2444:  2403:  2393:  2354:  2319:  2312:146874 2309:  2270:  2260:  2218:  2208:  2166:  2156:  2117:  2107:  2068:  2060:  2034:Nature 2010:  1969:  1928:  1918:  1879:  1838:  1830:  1794:  1748:  1738:  1696:  1688:  1653:  1643:  1601:  1591:  1550:  1543:311015 1540:  1498:  1490:  1449:  1398:  1391:316947 1388:  1349:  1341:  1212:DIS3L1 1166:84–100 1135:EXOSC9 1125:Rrp45p 1100:EXOSC8 1090:Rrp43p 1065:EXOSC7 1055:Rrp42p 1052:hRrp42 1030:EXOSC6 995:EXOSC5 985:Rrp46p 982:hRrp46 960:EXOSC4 947:hRrp41 925:EXOSC3 918:(Rrp4) 915:Rrp40p 912:hRrp40 890:EXOSC2 855:EXOSC1 839:S1 RBD 804:Human 754:tumors 750:cancer 652:thymus 570:PNPase 554:5' end 450:3' end 347:DIS3L1 314:3' end 277:PNPase 256:below. 254:legend 236:below. 234:legend 165:cause 159:cancer 133:3β€² end 54:legend 3836:S2CID 3764:S2CID 3551:S2CID 3502:S2CID 3333:83843 3082:S2CID 3031:S2CID 2982:S2CID 2582:S2CID 2531:S2CID 2450:S2CID 2066:S2CID 2030:(PDF) 1836:S2CID 1694:S2CID 1496:S2CID 1347:S2CID 1192:Dis3 1186:Rrp44 1160:Rrp6p 1131:34–49 1116:Rrp45 1096:30–44 1081:Rrp43 1061:29–32 1058:Rrp42 1046:Rrp42 1026:24–37 1020:Mtr3p 1017:hMtr3 991:25–28 976:Rrp46 956:26–28 953:Rrp41 941:Rrp41 921:27–32 906:Rrp40 886:28–39 880:Rrp4p 877:hRrp4 851:21–32 842:hCsl4 820:(kD) 700:ELISA 644:serum 486:below 366:with 330:Rrp44 205:below 183:RNase 18:Rrp44 3828:PMID 3799:PMID 3781:Cell 3756:PMID 3717:PMID 3674:PMID 3662:1779 3645:PMID 3635:ISBN 3601:PMID 3543:PMID 3525:Cell 3494:PMID 3459:PMID 3424:PMID 3373:PMID 3338:PMID 3285:PMID 3250:PMID 3215:PMID 3166:PMID 3131:PMID 3074:PMID 3023:PMID 3005:Cell 2974:PMID 2939:PMID 2904:PMID 2855:PMID 2806:PMID 2754:PMID 2713:PMID 2664:PMID 2623:PMID 2574:PMID 2555:Cell 2523:PMID 2474:Cell 2442:PMID 2424:Cell 2401:PMID 2352:PMID 2317:PMID 2268:PMID 2216:PMID 2164:PMID 2115:PMID 2058:PMID 2008:PMID 1967:PMID 1926:PMID 1877:PMID 1828:PMID 1792:PMID 1746:PMID 1720:Cell 1686:PMID 1651:PMID 1641:ISBN 1599:PMID 1548:PMID 1488:PMID 1470:Cell 1447:PMID 1396:PMID 1339:PMID 1320:Cell 1285:The 1278:The 1208:DIS3 1151:Rrp6 1087:OIP2 1011:Mtr3 883:Rrp4 871:Rrp4 848:Csl4 836:Csl4 721:and 380:Rrp6 363:2hbj 351:DIS3 291:and 281:tRNA 275:and 157:for 64:(or 60:The 49:2NN6 3894:RNA 3820:doi 3789:doi 3785:125 3748:doi 3707:PMC 3699:doi 3666:doi 3627:doi 3591:PMC 3583:doi 3533:doi 3529:116 3486:doi 3451:doi 3414:PMC 3404:doi 3365:doi 3328:PMC 3318:doi 3277:doi 3242:doi 3205:PMC 3197:doi 3158:doi 3121:doi 3109:322 3066:doi 3054:457 3013:doi 3009:121 2966:doi 2931:doi 2894:PMC 2886:doi 2878:RNA 2845:PMC 2837:doi 2796:PMC 2788:doi 2744:doi 2740:282 2703:PMC 2695:doi 2691:177 2654:doi 2613:doi 2564:doi 2560:127 2515:doi 2483:doi 2479:131 2432:doi 2428:121 2391:PMC 2383:doi 2375:RNA 2344:doi 2307:PMC 2299:doi 2258:PMC 2250:doi 2206:PMC 2198:doi 2154:PMC 2146:doi 2105:PMC 2097:doi 2050:doi 2038:456 1998:doi 1957:doi 1916:PMC 1908:doi 1867:doi 1863:278 1820:doi 1782:hdl 1774:doi 1770:323 1736:PMC 1728:doi 1724:127 1678:doi 1633:doi 1589:PMC 1581:doi 1538:PMC 1530:doi 1478:doi 1474:107 1437:hdl 1427:doi 1423:276 1386:PMC 1378:doi 1329:doi 1201:n/a 1163:n/a 784:). 748:of 638:or 513:or 353:). 342:all 318:RNA 316:of 82:RNA 45:PDB 3885:: 3834:. 3826:. 3816:12 3814:. 3797:. 3783:. 3779:. 3762:. 3754:. 3746:. 3734:61 3732:. 3715:. 3705:. 3693:. 3689:. 3672:. 3660:. 3643:. 3633:. 3599:. 3589:. 3579:44 3577:. 3573:. 3549:. 3541:. 3527:. 3523:. 3500:. 3492:. 3482:17 3480:. 3457:. 3445:. 3422:. 3412:. 3398:. 3394:. 3371:. 3361:56 3359:. 3336:. 3326:. 3312:. 3306:. 3283:. 3273:50 3271:. 3248:. 3238:28 3236:. 3213:. 3203:. 3193:81 3191:. 3187:. 3164:. 3154:14 3152:. 3129:. 3119:. 3107:. 3103:. 3080:. 3072:. 3064:. 3052:. 3029:. 3021:. 3007:. 3003:. 2980:. 2972:. 2960:. 2937:. 2927:30 2925:. 2902:. 2892:. 2882:13 2880:. 2876:. 2853:. 2843:. 2833:33 2831:. 2827:. 2804:. 2794:. 2784:18 2782:. 2778:. 2766:^ 2752:. 2738:. 2734:. 2711:. 2701:. 2689:. 2685:. 2662:. 2650:12 2648:. 2644:. 2621:. 2609:20 2607:. 2603:. 2580:. 2572:. 2558:. 2552:. 2529:. 2521:. 2511:14 2509:. 2497:^ 2477:. 2471:. 2448:. 2440:. 2426:. 2422:. 2399:. 2389:. 2379:11 2377:. 2373:. 2350:. 2340:83 2338:. 2315:. 2305:. 2295:25 2293:. 2289:. 2266:. 2256:. 2246:29 2244:. 2240:. 2228:^ 2214:. 2204:. 2194:29 2192:. 2188:. 2176:^ 2162:. 2152:. 2142:27 2140:. 2136:. 2113:. 2103:. 2093:37 2091:. 2087:. 2064:. 2056:. 2048:. 2036:. 2032:. 2006:. 1994:14 1992:. 1988:. 1965:. 1951:. 1947:. 1924:. 1914:. 1904:13 1902:. 1898:. 1875:. 1861:. 1857:. 1834:. 1826:. 1816:62 1814:. 1790:. 1780:. 1768:. 1744:. 1734:. 1722:. 1718:. 1706:^ 1692:. 1684:. 1674:12 1672:. 1649:. 1639:. 1611:^ 1597:. 1587:. 1575:. 1569:. 1546:. 1536:. 1526:11 1524:. 1520:. 1494:. 1486:. 1472:. 1468:. 1445:. 1435:. 1421:. 1417:. 1394:. 1384:. 1374:13 1372:. 1368:. 1345:. 1337:. 1325:91 1323:. 1317:. 1305:^ 1183:11 1148:10 818:MW 811:) 717:, 713:, 598:. 578:. 550:3' 545:. 468:. 173:. 123:, 107:, 3842:. 3822:: 3805:. 3791:: 3770:. 3750:: 3723:. 3701:: 3695:8 3680:. 3668:: 3651:. 3629:: 3607:. 3585:: 3557:. 3535:: 3508:. 3488:: 3465:. 3453:: 3447:6 3430:. 3406:: 3400:7 3379:. 3367:: 3344:. 3320:: 3314:4 3291:. 3279:: 3256:. 3244:: 3221:. 3199:: 3172:. 3160:: 3137:. 3123:: 3115:: 3088:. 3068:: 3060:: 3037:. 3015:: 2988:. 2968:: 2962:7 2945:. 2933:: 2910:. 2888:: 2861:. 2839:: 2812:. 2790:: 2760:. 2746:: 2719:. 2697:: 2670:. 2656:: 2629:. 2615:: 2588:. 2566:: 2537:. 2517:: 2491:. 2485:: 2456:. 2434:: 2407:. 2385:: 2358:. 2346:: 2323:. 2301:: 2274:. 2252:: 2222:. 2200:: 2170:. 2148:: 2121:. 2099:: 2072:. 2052:: 2044:: 2014:. 2000:: 1973:. 1959:: 1953:8 1932:. 1910:: 1883:. 1869:: 1842:. 1822:: 1798:. 1784:: 1776:: 1752:. 1730:: 1700:. 1680:: 1657:. 1635:: 1605:. 1583:: 1577:4 1554:. 1532:: 1502:. 1480:: 1453:. 1439:: 1429:: 1402:. 1380:: 1353:. 1331:: 1113:9 1078:8 1043:7 1008:6 973:5 938:4 903:3 868:2 833:1 34:. 20:)

Index

Rrp44
Exosome (vesicle)

PDB
2NN6
legend
protein
complex
RNA
eukaryotic
archaea
bacteria
degradosome
cytoplasm
nucleus
nucleolus
substrates
messenger RNA
ribosomal RNA
small RNAs
3β€² end
autoantibodies
autoimmune diseases
PM/Scl overlap syndrome
antimetabolic
chemotherapies
cancer
exosome component 3
pontocerebellar hypoplasia
motor neuron disease

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑